Geneos Wealth Management’s Fidelity Blue Chip Value ETF FBCV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-479
Closed -$14K 2817
2021
Q4
$14K Hold
479
﹤0.01% 2043
2021
Q3
$13K Buy
+479
New +$13.7K ﹤0.01% 2108

Other funds holding FBCV

Geneos Wealth Management's FBCV Position: Q1 2022 in Review

Geneos Wealth Management sold out of Fidelity Blue Chip Value ETF (FBCV) in Q1 2022, closing a stake of 479 shares — an estimated $14K sold.

Geneos Wealth Management first reported a position in FBCV in Q3 2021 and held it in 2 quarters. The position peaked at $14K in Q4 2021. 11 funds tracked by Wall St. Rank hold FBCV as of Q1 2022.

  • Geneos Wealth Management reported no remaining Fidelity Blue Chip Value ETF position as of Q1 2022 after selling out during the quarter.
  • Geneos Wealth Management sold 479 Fidelity Blue Chip Value ETF shares in Q1 2022, an estimated $14K.
  • Geneos Wealth Management first reported a position in Fidelity Blue Chip Value ETF in Q3 2021 and held it in 2 quarters.
  • Geneos Wealth Management's Fidelity Blue Chip Value ETF position peaked at $14K in Q4 2021.
  • 11 funds tracked by Wall St. Rank held Fidelity Blue Chip Value ETF as of Q1 2022.

Based on Geneos Wealth Management's 13F filing for Q1 2022, filed 16 May 2022.